Research indicates that mutations in the CHCHD2 gene may contribute to the pathogenic mechanisms underlying neurodegenerative diseases such as Parkinson’s disease, frontotemporal dementia, and Alzheimer’s disease, and are also associated with apoptosis and cancer. This evidence concerns the gene CHCHD2 and Parkinson disease.